Gynecologic Oncology
Overview
Gynecologic Oncology is a renowned peer-reviewed journal dedicated to the study and treatment of gynecologic cancers. It publishes cutting-edge research, clinical trials, and reviews on topics like ovarian, cervical, uterine, and vulvar cancers. With a focus on advancing knowledge and improving patient outcomes, this journal serves as a vital resource for oncologists, researchers, and healthcare professionals in the field of gynecologic oncology.
Details
Details
Abbr.
Gynecol Oncol
Start
1972
End
Continuing
Frequency
Monthly
p-ISSN
0090-8258
e-ISSN
1095-6859
Country
United States
Language
English
Metrics
Metrics
h-index / Ranks: 859
186
SJR / Ranks: 1702
1627
CiteScore / Ranks: 2064
8.40
Recent Articles
1.
Salinaro J, Singh K, Sands N, Gill V, Perati S, James N, et al.
Gynecol Oncol
. 2025 Mar;
195:115-121.
PMID: 40088505
Objectives: Although multiple HER2 scoring criteria exist, the optimal strategy to identify patients with gynecologic malignancies who may benefit from HER2-directed therapies remains unknown. The objectives of this study were...
2.
Engh A, Rueegg C, Bjerre Trent P, Opheim L, Engeskaug I, Nordskar N, et al.
Gynecol Oncol
. 2025 Mar;
195:82-88.
PMID: 40086214
Objective: The aims of this cross-sectional study were to describe the prevalence of self-reported lower extremity lymphedema (LEL) by different physical activity (PA) levels and to examine if higher levels...
3.
Lindemann K, Siegenthaler F, Lande K, Casas-Arozamena C, Nebdal D, Rau T, et al.
Gynecol Oncol
. 2025 Mar;
195:98-105.
PMID: 40081113
Objective: At present, no reliable blood-based biomarkers have been established for patients with endometrial cancer. Liquid biopsies, which can detect circulating tumor DNA (ctDNA), provide a non-invasive way to assess...
4.
Zammarrelli 3rd W, Nandakumar S, Kertowidjojo E, Nguyen B, Moukarzel L, Da Cruz Paula A, et al.
Gynecol Oncol
. 2025 Mar;
195:89-97.
PMID: 40081112
Objective: The molecular underpinnings of primary treatment-naïve endometrial carcinoma (EC) are well described. Here we sought to characterize the genomic landscape of distant metastatic EC. Methods: Distant metastatic ECs from...
5.
Tyan K, Liu K, Smart A, Feltmate C, Horowitz N, Muto M, et al.
Gynecol Oncol
. 2025 Mar;
195:75-81.
PMID: 40058185
Background: There are limited data around adjuvant radiotherapy following surgical management for patients with early-stage uterine carcinosarcoma (UCS). We compared outcomes for patients with early-stage UCS who underwent adjuvant chemotherapy...
6.
Carter J, Huang H, Monk B, Kim Y, Kim M, Stuckey A, et al.
Gynecol Oncol
. 2025 Mar;
195:50-58.
PMID: 40058184
Objective: To examine patient outcomes before and after cone biopsy (CB) or simple hysterectomy (SH) and pelvic lymph node dissection (PLND) for bladder, bowel, and sexual function, quality of life...
7.
Bae-Jump V, Sill M, Gehrig P, Merker J, Corcoran D, Pfefferle A, et al.
Gynecol Oncol
. 2025 Mar;
195:66-74.
PMID: 40056832
Introduction: We evaluated the efficacy of the addition of the anti-diabetic drug metformin to standard-of-care paclitaxel and carboplatin (PC) in patients with advanced and recurrent endometrial cancer (EC). Methods: In...
8.
Covens A, Huang H, Monk B, Kim Y, Kim M, DiSilvestro P, et al.
Gynecol Oncol
. 2025 Mar;
195:59-65.
PMID: 40056831
Objective: To estimate the efficacy and perioperative morbidity of nonradical surgery (simple hysterectomy [SH] or cone biopsy [CB] plus pelvic lymphadenectomy [PLND] and to report pregnancy outcomes after CB. Methods:...
9.
La Torre F, Hurni Y, Farsi E, Nardi E, Castiglione F, Sorbi F, et al.
Gynecol Oncol
. 2025 Mar;
195:45-49.
PMID: 40054046
Background/objective: Adenomyosis is a benign uterine disorder characterized by an inflammatory and hyperestrogenic state. Its association with endometrial cancer (EC) remains controversial. This study aimed to investigate the correlation between...
10.
Li X, Wang Z, Man X, Dai X, Zhou Q, Zhang S
Gynecol Oncol
. 2025 Mar;
195:34-44.
PMID: 40054045
Epithelial ovarian carcinoma (EOC), the most lethal gynecologic cancer, is often diagnosed at advanced stages, which urge us to explore the novel therapeutic strategies. Mouse models have played a crucial...